The French government has repealed the decree authorizing the use of hydroxychloroquine to treat patients infected with the new coronavirus after a study has been published that warns of possible side effects of this medicine, which is derived from a malaria drug.
According to the study, published by The Lancet magazine and developed after an analysis of around 96,000 people, this malaria treatment used to date is associated with an increased risk of death and heart disease, which would hamper its use.
The World Health Organization (WHO) announced the suspension of clinical trials on Monday, and in France the government has decided to repeat the doubts already raised by the Supreme Public Health Council and the Medicines Agency. In this way, the Gallic executive published in the official bulletin the repeal of the decree that has approved the treatment since the end of March.
France has recorded more than 28,500 deaths from COVID-19, the disease derived from the new coronavirus. The total number of cases in French territory exceeds 180,000, with some of the restrictions on combating the pandemic being lifted.